Algo version: 0.98b
NanJing Pharmaceutical is listed at the SHH Exchange
NanJing Pharmaceutical [600713.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—General

Is NanJing Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, NanJing Pharmaceutical pays dividends. Last time was Friday 28th of June 2024 where the investors holding the stock on Friday 28th of June 2024 were paid CNY0.16 per share. Over the last 21 times between 1997 and 2024, NanJing Pharmaceutical has paid CNY2.157 with an average of CNY0.1 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for NanJing Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY4.48, you would have made a loss of CNY-0.160 per share or -3.57%

Yes, the average daily trading liquidity for NanJing Pharmaceutical is CNY5.90 million. You should therefore be able to get in and out of your positions relatively fast.

NanJing Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.11, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 1.10%, which is challenging.

We have calculated the inflation risk for NanJing Pharmaceutical to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.